4:45 MONARCH 3: Abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer ecancer 203 views - 8 years ago
3:17 MRTX9768: a synthetic lethal-based inhibitor designed to bind the PRMT5•MTA complex and target M... ecancer 894 views - 4 years ago
3:56 Comment: The success of immunotherapy means we have to change our mindset as we treat patients ecancer 34 views - 6 years ago